People · Operator
Named in public records as an officer, director or promoter · active 2020–2022 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Forge Biologics Holdings, LLC | — | Biotechnology | Series D+ | $160.0M | $3.8B | 2020 |
| Tellus Therapeutics, Inc. | — | Pharmaceuticals | Series B | $18.0M | $212.5M | 2021 |
Chris J. Garabedian at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chris J. Garabedian on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Timothy J. Miller | 1 | 2 |
| Eric J. Benner | 1 | 1 |
| Fred J. Callori | 1 | 1 |
| Frederick J. Callori | 1 | 1 |
| Molly J. Bonakdarpour | 1 | 1 |
| Matthew J. Hammond | 1 | 1 |
| Jason E. Kralic | 1 | 1 |
| Molly J. McCartin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.